/
Other
Stage III
11
Pipeline Programs↗
5
Active Trials↗
11
Companies Involved↗
Stage III is an emerging landscape with 11 programs across 11 companies. 7 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 37
Approved
No programs
Analysis
Modality Breakdown
11programs
Small molecule545%
Monoclonal antibody327%
Protein / enzyme218%
Antibody–drug conjugate19%
Modality classified for 100% of 11 pipeline programs.
Analysis
Trial Status
15
clinical trials
Terminated6 · 40%
Completed3 · 20%
Recruiting3 · 20%
Active, not recruiting2 · 13%
Unknown status1 · 7%
Clinical Trials
Trial Activity
15 trials
Evaluation of Local Application of Insulin Versus Hyaluronic Acid in Stage III Periodontitis Patients: A Randomized Controlled Clinical Trial
Recruiting·—·Phase 1·NCT07746206·45 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)